Dose-Proportionality and Food Effect Study of TNX-102 SL
NCT04164719
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
TNX-102 SL
Sponsor
Tonix Pharmaceuticals, Inc.